Healthcare Services

Gene Panel Market Growth Driven by Rising Cancer Prevalence

April 21, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Expansion In Market Value Is Forecasted For The Gene Panel Market Between 2026 And 2030?

The gene panel market has undergone rapid expansion in recent years. It is projected to increase from $2.47 billion in 2025 to $2.85 billion in 2026, at a compound annual growth rate (CAGR) of 15.3%. This historical growth can be attributed to advancements in next-generation sequencing, reduced sequencing expenditures, the adoption of clinical genetics, the proliferation of diagnostic laboratories, and oncology biomarker research.

The gene panel market is anticipated to experience significant expansion in the coming years. This market is projected to reach $4.96 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 14.9%. Key factors contributing to this anticipated growth include the advancements in personalized medicine, the broadening scope of hereditary disease testing, an increasing need for precision diagnostics, the incorporation of AI into genomic analysis, and more widespread clinical adoption. Prominent trends expected during this period involve the increasing embrace of multi-gene diagnostic panels, their expanded application in cancer risk evaluation, the development of customized gene panel testing, a growing desire for pharmacogenomic information, and the embedding of gene panels into clinical decision-making processes.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/gene-panel-global-market-report

Which Important Drivers Are Guiding The Gene Panel Market Growth?

The escalating prevalence of cancer is anticipated to fuel the expansion of the gene panel market. Cancer, characterized by the unchecked proliferation and dissemination of abnormal cells that can infiltrate and harm surrounding tissues and organs, is seeing an increase in cases. This surge is attributed to an aging global population, evolving lifestyle choices, various environmental exposures, and advancements in detection and diagnostic technologies. Gene panels play a vital role in addressing cancer by facilitating comprehensive genetic testing to pinpoint specific gene mutations and alterations, thereby informing personalized treatment approaches and improving patient outcomes. For example, in January 2023, PubMed, a US-based free search engine for biomedical and life sciences literature maintained by the United States National Library of Medicine, indicated that 2023 is projected to witness 1,958,310 new cancer cases and 609,820 cancer deaths in the United States. Hence, the rising incidence of cancer is a primary catalyst for the gene panel market’s growth.

Which Segment Categories Are Included In The Gene Panel Market Segment Analysis?

The gene panel market covered in this report is segmented –

1) By Product And Services: Test Kits, Testing Services

2) By Technology: Amplicon-Based, Hybridization-Based, Other Technologies

3) By Design: Predesigned Gene Panel, Customized Gene Panel

4) By Application: Cancer Risk Assessment, Diagnosis Of Congenital Diseases, Pharmacogenetics, Other Applications

5) By End-User: Research Institutes, Hospital, Diagnosis Centers, Pharmaceutical Companies, Other End-Users

Subsegments:

1) By Test Kits: Predesigned Gene Panels, Customized Gene Panels

2) By Testing Services: Cancer Risk Assessment Panels, Pharmacogenetic Testing Panels, Neurological Disorder Panels, Cardiovascular Disease Panels, Rare Disease Panels

What Trends Are Influencing The Evolution Of The Gene Panel Market?

Leading companies within the gene panel market are prioritizing the creation of advanced technologies, including oncology panels, with the aim of improving the precision, effectiveness, and breadth of cancer diagnosis and individualized treatment approaches. These oncology panels are specialized genetic tools designed to examine numerous genes linked to cancer, detecting genetic mutations and changes that assist in the diagnosis, prediction, and management of the disease. For example, in May 2023, Vizgen Inc., a biotechnology firm from the US, introduced the MERFISH PanCancer Pathways Panel, providing a customizable choice for scientists venturing into spatial genomics. These pre-configured panels are specifically designed for diverse research purposes, such as cancer investigations, and are engineered for superior error tolerance, ensuring dependable and consistent outcomes. By combining spatial data with gene expression information, these panels deliver more profound understandings of tumor microenvironments and cell interactions, thereby enabling more precise and individualized cancer research and the development of therapies. This introduction signifies a notable leap forward in spatial biology, empowering researchers to investigate intricate biological systems with an unprecedented degree of detail.

Who Are The Active Companies Shaping The Gene Panel Market?

Major companies operating in the gene panel market are F. Hoffmann-La Roche, Thermo Fisher Scientific, Quest Diagnostics, Eurofins Scientific, Agilent Technologies, Illumina, Qiagen, Myriad Genetics, Guardant Health, Invitae, Integrated DNA Technologies, Bio-Rad, Novogene, Fulgent Genetics, MedGenome, Centogene, Blueprint Genetics, BIONEER, BGI Group.

Get The Full Gene Panel Market Report:

https://www.thebusinessresearchcompany.com/report/gene-panel-global-market-report

Which Region Represents The Largest Share Of The Gene Panel Market?

North America was the largest region in the gene panel market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gene panel market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Gene Panel Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/gene-panel-global-market-report

Browse Through More Reports Similar to the Global Gene Panel Market 2026, By The Business Research Company

Genomics Market Report 2026

https://www.thebusinessresearchcompany.com/report/genomics-global-market-report

Genes Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/genes-therapy-global-market-report

Gene Expression Market Report 2026

https://www.thebusinessresearchcompany.com/report/gene-expression-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795